Pulse Biosciences (PLSE)

• Market cap: $1.17B
• 1 day: -0.86%
• 5 days: -4.14%
• 1 month: -2.53%
• 3 months: 14.07%
• 6 months: -3.34%
• Year to date: -2.47%
• 1 year: -1.36%
• 5 years: 43.03%
• 10 years: 316.07%
• Sector: Healthcare
• Industry: Medical Instruments & Supplies

About: Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.

Employees: 75